ED-Relevant Takeaways from the New AHA/ACC Hypertension Guideline

Figure 1: Condition-specific recommendations and blood pressure cutoffs provided by the AHA/ACC Hypertension Guideline.Abbreviations: AOI, acute organ injury; HBPM, home blood pressure monitoring.The latest American Heart Association (AHA)/American College of Cardiology (ACC) guideline on hypertension is applicable to emergency clinicians because it clarifies where acute treatment adds the most value for patients who present with markedly elevated BP. At a high level, the document emphasizes four themes: (1) get the measurement right; (2) separate hypertensive emergencies from severe but stable hypertension; (3) act decisively with intravenous therapy when acute target-organ injury is present; and (4) when it is not, initiate or intensify outpatient-style therapy, reinforce home monitoring, and hand off with a specific follow-up plan. These points support an emergency department (ED) practice pattern that improves safety, preserves critical care resources for those who truly need them, and meaningfully reduces long-term cardiovascular risk for most patients who arrive with uncontrolled BP but no evidence of acute organ damage.1 First, the guideline calls for accurate and reproducible measurement of BP as the foundation for any decision. In the ED, this means not relying solely on a single triage value when the clinical stakes are high. Although it may not always be viable for patients with high time-sensitivity cases, recommendations for an accurate BP measurement include using a validated device with an appropriate cuff size; positioning the patient seated with feet flat, back supported, and the arm supported at heart level; avoiding talking during the measurement; and allowing at least 5 minutes of rest beforehand. When these measures cannot be reasonably employed, clinicians should be aware that they may influence the BP reading. Moreover, multiple readings that are averaged may help distinguish a spurious value from a true measurement. If the patient takes antihypertensives at home, documentation of the timing of the last dose and the patient's usual BP pattern can help to distinguish a new increase in BP from chronically uncontrolled hypertension. The guideline's measurement standards are straightforward and, when followed, reduce misclassification that can lead to either unnecessary treatment or missed emergencies. Second, the ED decision point hinges on whether there is new or worsening target-organ injury. The guideline, unchanged from previous versions of the AHA/ACC, defines hypertensive emergency as systolic BP ≥180 mmHg and/or diastolic BP ≥120 mmHg in which acute target-organ damage is present. In these cases, such as acute aortic dissection, hypertensive encephalopathy, intracerebral hemorrhage, and acute coronary syndrome, immediate BP reduction with intravenous agents and continuous monitoring is required, and oral agents are not appropriate for this initial phase of management. Conversely, severe asymptomatic hypertension (sometimes referred to as a “hypertensive urgency”) lacks acute organ injury and does not usually require hospital admission or rapid IV BP lowering. In such cases, the guideline favors restarting or intensifying chronic therapy while addressing anxiety and adherence barriers and arranging prompt follow-up, rather than reflexively hospitalizing the patient.1 The AHA/ACC guideline also offers condition-specific BP targets and treatment algorithms including disposition recommendations (Figure 1). When no acute organ injury is identified, emergency providers still have an important therapeutic role. In many patients with stage 2 hypertension, defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg, the guidelines support starting two antihypertensive agents from different classes and arranging follow-up at approximately 1 month. Patients with stage 1 hypertension and a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of 10% or higher should also begin medication alongside lifestyle therapy with a similar 1-month follow-up cadence. For those with elevated BP or low-risk stage 1 hypertension, lifestyle modification with repeat assessment in 3-6 months is appropriate. A particular group relevant to ED physicians consists of patients with very high average BP, often defined in practice as systolic ≥180 mmHg or diastolic ≥110 mmHg, who are asymptomatic. They warrant evaluation and prompt initiation or intensification of therapy rather than passive deferral. Selecting once-daily medications facilitates adherence, and using fixed-dose combinations (eg, an Angiotensin-Covering Enzyme (ACE) inhibitor or ARB paired with a thiazide diuretic, or a calcium-channel blocker paired with an ACE inhibitor) is an effective strategy to reach targets with fewer pills and simpler instructions. Targets remain clear: for most healthy adults, the goal is